Canada markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
83.33+2.57 (+3.18%)
At close: 04:00PM EDT
83.42 +0.09 (+0.11%)
After hours: 06:53PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
755,127
724,531
587,276
649,158
Other Short Term Investments
318,683
567,006
426,599
416,228
Total Cash
1,073,810
1,291,537
1,013,875
1,065,386
Net Receivables
633,704
461,316
373,399
448,351
Inventory
1,107,183
894,083
776,669
698,548
Other Current Assets
141,391
104,521
110,442
129,934
Total Current Assets
2,956,088
2,751,457
2,274,385
2,342,219
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,933,222
1,875,511
1,756,035
1,668,066
Accumulated Depreciation
-867,089
-802,145
-720,574
-635,595
Net property, plant and equipment
1,066,133
1,073,366
1,035,461
1,032,471
Equity and other investments
611,135
333,835
507,793
285,473
Goodwill
196,199
196,199
196,199
196,199
Intangible Assets
294,701
338,569
388,652
417,271
Other long-term assets
171,538
176,236
152,121
142,237
Total non-current assets
3,885,515
3,623,617
3,730,387
3,505,801
Total Assets
6,841,603
6,375,074
6,004,772
5,848,020
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
493,877
-
-
-
Accounts Payable
315,509
231,238
199,678
191,429
Taxes payable
2,651
16,213
1,213
9,661
Accrued liabilities
6,190
8,288
6,043
4,488
Deferred revenues
4,620
711
6,956
152
Other Current Liabilities
33,853
28,526
54,495
17,798
Total Current Liabilities
1,177,024
588,884
546,497
492,548
Non-current liabilities
Long Term Debt
593,095
1,083,019
1,079,077
1,075,145
Other long-term liabilities
119,935
100,015
113,529
174,325
Total non-current liabilities
713,030
1,183,034
1,192,606
1,249,470
Total Liabilities
1,890,054
1,771,918
1,739,103
1,742,018
Stockholders' Equity
Common Stock
189
186
184
182
Retained Earnings
-621,554
-789,199
-930,760
-861,609
Accumulated other comprehensive income
-28,788
-3,867
14,432
-16,139
Total stockholders' equity
4,951,549
4,603,156
4,265,669
4,106,002
Total liabilities and stockholders' equity
6,841,603
6,375,074
6,004,772
5,848,020